Related Experiment Video
Updated: Aug 10, 2026

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
Published on: August 15, 2018
Naloxone during neonatal resuscitation: acknowledging the unknown
Ruth Guinsburg1, Myra H Wyckoff
1Department of Pediatrics, Division of Neonatal Medicine, Federal University of São Paulo, Rua Vicente Félix 77/09, São Paulo, SP 01410-020, Brazil. ruthgbr@netpoint.com.br
Naloxone is not recommended for routine use in newborns during delivery resuscitation. There is insufficient evidence to support its benefits, and potential harmful effects exist.
Area of Science:
- Neonatal Resuscitation
- Pharmacology
- Evidence-Based Medicine
Background:
- Current neonatal resuscitation guidelines lack robust evidence.
- Recommendations for naloxone use in neonates are not well-supported by studies.
Purpose of the Study:
- To evaluate the evidence supporting naloxone administration in neonatal resuscitation.
- To determine if routine naloxone use is beneficial for depressed neonates.
Main Methods:
- Review of existing studies on naloxone in neonatal resuscitation.
- Analysis of data regarding naloxone concentration, routes, and doses.
Main Results:
- No studies currently support or refute existing naloxone recommendations.
- No significant documented improvement in neonatal outcomes with naloxone use.
Conclusions:
- Routine naloxone administration in the delivery room is not recommended for depressed neonates.
- Potential short- and long-term adverse effects of naloxone in neonates warrant caution.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmaceutical Poisoning: Treatment Strategies
Drug Delivery: Enteral Route
Drugs in...
Parenteral Anesthetics: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Cardiopulmonary Resuscitation II: ACLS Airway Management

